Clinical Trial Update: Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating docetaxel in women with ovarian epithelial cancer or primary peritoneal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Ovarian Cancer, Peritoneal Cavity Cancer | Phase 2 | Status: COMPLETED